RxDoctor Payments Data

Thomas Olson

Podiatrist · Rock Hill, SCNPI 1114908860

Payments from drug & device makers

What this record shows

This record is dominated by other: $4,200 of the $4,317 with a category attached, or 97.3%. Convatec Inc. accounts for 97.3% of it on its own, with 6 other manufacturers making up the rest. 2024 is the largest year on record at $4,200, more than ten times the $53 reported in 2019.

$4,317in general payments, 2019–2025

Across 9 payments — averaging $479.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$4K
  • Smith+Nephew$48
  • Amgen$17
  • Triad Life Sciences Inc.$16
  • Zyla Life Sciences, Inc.$12
  • Merck$12
  • plus $11 from 1 others

What the payments were for

  • Food & beverage$1173%
  • Other$4,20097%

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Convatec Inc.1$4,200
Smith+Nephew3$48
Amgen1$17
Triad Life Sciences Inc.1$16
Zyla Life Sciences, Inc.1$12
Merck1$12
Assertio Therapeutics, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,317 in reported general payments places this provider in the 80th percentile of 61 podiatrist providers in South Carolina.

See all podiatrist providers in South Carolina

Medicare billing

Part B allowed, 2024
$112,204
Medicare patients
307
Services billed
1,540

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl17$337
Diclofenac Sodium34$308
Doxycycline Hyclate17$85
Cephalexin31$75
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$29
Prednisone11$21

Paid to pharmacies, not to this prescriber.

Other podiatrist in Rock Hill

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →